secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001213900-22-032224
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Three Emmaus directors resign after dispute with CEO over financial oversight and cost cuts
--------------------------------------------------------------------------------

- Lori Teranishi, Alfred Lui, and Jane Pine Wood resigned June 8, 2022, at CEO Yutaka Niihara's request.
- Directors stated resignations followed their repeated requests for financial information and business plans.
- CEO takes voluntary 30% salary reduction for three months; other senior management take 10% cuts.
- Non-essential spending cut, including suspension of EJ Holdings facility retrofitting in Ube, Japan.
- Company expects positive operating income later this year via increased Endari sales in U.S. and UAE/GCC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390022032224/0001213900-22-032224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390022032224/ea161387-8k_emmauslife.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-032224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer